Naomi Elizabeth Wagner

Ms. Naomi Elizabeth Wagner

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2024 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
SYShaden H. Yassin
Shaden H. Yassin
NWNaomi Elizabeth Wagner
Naomi Elizabeth Wagner
TKThomas Khuu
Thomas Khuu
RSRyan Schmidt
Ryan Schmidt
AIAustin D. Igelman
Austin D. Igelman
SBShyamanga R Borooah
Shyamanga R Borooah

20 January 2022 in Ophthalmic Genetics
Verified
Journal Article
Open access
ACAndrew J. Catomeris
Andrew J. Catomeris
BBBrian G Ballios
Brian G Ballios
RSRiccardo Sangermano
Riccardo Sangermano
NWNaomi Elizabeth Wagner
Naomi Elizabeth Wagner
JCJason I. Comander
Jason I. Comander
RHRachel M. Huckfeldt
Rachel M. Huckfeldt
Variants in RCBTB1 were recently described to cause a retinal dystrophy with only eight families described to date and a predominant phenotype of macular atrophy and peripheral reticular degenerati...

31 July 2024 in Ophthalmology Retina
Verified
Journal Article
Closed access
FKFritz Kalaw
Fritz Kalaw
NWNaomi Elizabeth Wagner
Naomi Elizabeth Wagner
TOThiago Barros de Oliveira
Thiago Barros de Oliveira
LELesley A. Everett
Lesley A. Everett
PYPaul Yang
Paul Yang
SBShyamanga R Borooah
Shyamanga R Borooah

14 September 2021 in Journal of Genetic Counseling
Verified
Journal Article
Open access
PDF file
NWNaomi Elizabeth Wagner
Naomi Elizabeth Wagner
SWSarah Witherington
Sarah Witherington
LWLarissa Waldman
Larissa Waldman
LRLauren Ryan
Lauren Ryan
MHMelanie W. Hardy
Melanie W. Hardy
Genetic counseling services changed due to the COVID‐19 pandemic. Many genetic counselors (GCs) moved from in‐person to telehealth services. Others were redeployed by choice or necessity, using their expertise to provide COVID‐19 care and education. For some, their employment status changed due to budgetary constraints or decreasing referrals. This study surveyed North American GCs to assess the relative use of genetic counseling Practice‐Based Competencies (PBCs) as a proxy for the skills used during the first wave of the pandemic, whether GCs were in their current role or in new or adjusted roles. A secondary aim was to determine whether GCs believe their training should be refocused in view of the workforce shifts posed by the pandemic. The survey comprised closed‐ and open‐ended questions and was completed in full by 97 respondents. The study population was representative of the general genetic counseling workforce in terms of gender, race/ethnicity, age, and practice area when compared to the National Society of Genetic Counselors 2020 Professional Status Survey. Most participants (97.9%) indicated that the COVID‐19 pandemic resulted in a change to their work, and 89.7% used at least one PBC at a different frequency than before the pandemic. The most significant change was the adaptation of genetic counseling skills for varied service delivery models: 83.5% of respondents indicated that their roles and responsibilities moved to a remote setting and/or utilized telehealth. The majority of participants felt competent using the PBCs during the pandemic. Major themes that emerged from the qualitative data were as follows: (a) adaptation of service delivery, (b) translation of genetic counseling skills, and (c) provision of psychosocial support. This study highlights practice changes for GCs due to the COVID‐19 pandemic as well as the increased use of, and need for focused training in, varied service delivery models.

26 November 2025 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
NWNaomi Elizabeth Wagner
Naomi Elizabeth Wagner
SAShadi M. AlAshwal
Shadi M. AlAshwal
JLJerica Lenberg
Jerica Lenberg
LBLynne M Bird
Lynne M Bird
SCSophia Ceulemans
Sophia Ceulemans
SBShyamanga Borooah
Shyamanga Borooah

13 April 2021 in medRxiv
Verified
Preprint
Open access
PDF file
EZErin Zampaglione
Erin Zampaglione
MMMatthew Maher
Matthew Maher
EPEmily M. Place
Emily M. Place
NWNaomi Elizabeth Wagner
Naomi Elizabeth Wagner
SDStephanie DiTroia
Stephanie DiTroia
KBKinga Bujakowska
Kinga Bujakowska
Purpose In Mendelian disease diagnosis, variant analysis is a repetitive, error-prone, and time-consuming process. To address this, we have developed the Mendelian Analysis Toolkit (MATK), a configurable automated variant ranking program. Methods MATK aggregates variant information from multiple annotation sources and uses expert-designed rules with parameterized weights to produce a ranked list of potentially causal solutions. MATK performance was measured by a comparison of MATK-aided versus human domain-expert analyses of 1060 inherited retinal degeneration (IRD) families investigated with an IRD-specific gene panel (589 families) and exome sequencing (471 families). Results When comparing MATK-assisted analysis to expert curation, we found that 97.3% (541/556) of potential solutions found by experts were also identified by the MATK-assisted analysis. Furthermore, MATK-assisted analysis identified 114 additional potential solutions. The software also showed utility in data reanalysis after remapping to the GRCh38 genome build. Conclusion MATK expedites the process of identifying likely solving variants in Mendelian traits and helps to remove variability coming from human error and researcher bias. MATK facilitates data re-analysis to keep up with the constantly improving annotation sources and NGS processing pipelines. The software is open source and available at https://gitlab.partners.org/meei-ogi-bioinformatics/MendelAnalysis